Peptides: Legal and Regulatory Risks 503A Compounding Pharmacies Must Understand RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA takes first step in possible reversal of ban on some peptides The Washington Post The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York US FDA to convene expert panel to review wider access to some peptides Reuters RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion